Evidence map›Paper›PMID 34663621›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2021

Cutting Edge: DOCK8 Regulates a Subset of Dendritic Cells That Is Critical for the Development of Experimental Autoimmune Encephalomyelitis.

Asanga Weliwitigoda, Pushpalatha Palle, Melissa Gessner, Nicholas W Hubbard, Mohamed Oukka, Estelle Bettelli

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Asanga WeliwitigodaImmunology Program, Benaroya Research Institute, Seattle, WA; and.
Pushpalatha PalleImmunology Program, Benaroya Research Institute, Seattle, WA; and.ORCID 0000-0003-1536-5558
Melissa GessnerImmunology Program, Benaroya Research Institute, Seattle, WA; and.
Nicholas W HubbardDepartment of Immunology, University of Washington, Seattle, WA.ORCID 0000-0002-6322-4840
Mohamed OukkaDepartment of Immunology, University of Washington, Seattle, WA.
Estelle BettelliImmunology Program, Benaroya Research Institute, Seattle, WA; and ebettelli@benaroyaresearch.org.ORCID 0000-0001-5251-3463
University of Washington · US

Funding

Function of a novel subset of dendritic cells in EAER21NS077116 · NINDS · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI BETTELLI, ESTELLE · 2012 to 2013
$466k
NINDS NIH HHS R21 NS077116
6 · The paper itself

Abstract

Dedicator of cytokinesis 8 (DOCK8) is a guanine nucleotide exchange factor with an essential role in cytoskeletal rearrangement, cell migration, and survival of various immune cells. Interestingly, DOCK8-deficient mice are resistant to the development of experimental autoimmune encephalomyelitis (EAE). To understand if EAE resistance in these mice results from an alteration in dendritic cell (DC) functions, we generated mice with conditional deletion of DOCK8 in DCs and observed attenuated EAE in these mice compared with control mice. Additionally, we demonstrated that DOCK8 is important for the existence of splenic conventional DC2 and lymph node migratory DCs and further established that migratory DC, rather than resident DC, are essential for the generation and proliferation of pathogenic T cell populations upon immunization with myelin Ag in adjuvant. Therefore, our data suggest that limiting migratory DCs through DOCK8 deletion and possibly other mechanisms could limit the development of CNS autoimmunity.

Indexed as

AnimalsDendritic CellsEncephalomyelitis, Autoimmune, ExperimentalFemaleGuanine Nucleotide Exchange FactorsMaleMiceMice, Inbred C57BLDock8 protein, mouseGuanine Nucleotide Exchange Factors

Identifiers

PMID34663621
PMCPMC8901115
OpenAlexW3205418404

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.